Shai N. Gozani, M.D., Ph.D. founded NeuroMetrix, Inc. in 1996 as a spin-off from the Massachusetts Institute of Technology. NeuroMetrix is a publicly-traded (Nasdaq:NURO) medical technology company that develops innovative wearable technology and point-of-care neurodiagnostic devices. The company’s products are used all over the world to help physicians and patients better manage chronic pain, neurological diseases, and sleep disorders. Over 2.5 million patients have benefited from the NeuroMetrix’s technology over the past 15 years. Dr. Gozani has led the company from a venture capital-backed start-up, through an initial public offering on Nasdaq, through development of a successful diagnostics business, and presently into the wearable technology sector. Dr. Gozani currently serves as Chairman of the board of directors and as President and Chief Executive Officer. Dr. Gozani has published over 30 peer-reviewed scientific articles and has been awarded 25 U.S. and international patents. Dr. Gozani holds a B.A. degree in Computer Science, an M.S. degree in Electrical Engineering & Computer Science (Biomedical Engineering Focus) and a Ph.D. in Neurobiology from the University of California, Berkeley. He also received an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology at M.I.T.
Winning the War on Diabetes